Resources and additional information

Resources and additional information.

Resources and additional
information

Resources and additional information

Resources and additional information.

Helpful resources for your practice


Get materials and forms designed with information about accessing, acquiring, and administering YEZTUGO.

HCP resources


Patient resources


Gilead medical information


A resource for US healthcare professionals with scientific and clinical information on Gilead products.


References:
  1. Bekker LG, Das M, Abdool Karim Q, et al; PURPOSE 1 study team. Twice-yearly lenacapavir or daily F/TAF for HIV prevention in cisgender women. N Engl J Med. 2024;391(13):1179-1192.
  2. Kelley CF, Acevedo-Quiñones M, Agwu AL, et al; PURPOSE 2 study team. Twice-yearly lenacapavir for HIV prevention in men and gender-diverse persons. N Engl J Med. 2025;392(13):1261-1276.
  3. YEZTUGO. Prescribing information. Gilead Sciences, Inc.; 2025.
  4. Department of Health and Human Services. Guidelines for use of antiretroviral agents in adults and adolescents with HIV. Clinical info. Updated September 12, 2024. Accessed May 13, 2025. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf